Morgan Stanley Virtual 19th Annual Global Healthcare Conference

September 13, 2021

Safe Harbor Statement

This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing.

Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.

Morgan Stanley Virtual 19th Annual Global Healthcare Conference, September 13, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

2

Agenda

01

Company Highlights

02

03

04

Strategic update

Financial review

Attachments

Q2/21 &

Outlook FY/21

Morgan Stanley Virtual 19th Annual Global Healthcare Conference, September 13, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

3

A Global Leader in Health Care Products and Services

in sales (FY/2020)

€ 36.3 bn

Global presence in 100+

countries

Leading market

#1 positions

Long-term opportunities in growing, non-cyclicalmarkets

100 +

Employees

worldwide

(as of June 30, 2021)

310,000+

Strong financial performance and cash flow generation

Morgan Stanley Virtual 19th Annual Global Healthcare Conference, September 13, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

4

Investment Highlights

Diversified healthcare Group

Leading positions in

Resilient business model

with four strong business

growing non-cyclical

based on megatrends

segments

markets

healthcare and demographics

Purpose-driven business

Strong financial

Reliable

delivers sustainable

performance and cash

dividend growth

contribution to society

flow generation

Morgan Stanley Virtual 19th Annual Global Healthcare Conference, September 13, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

5

Attachments

  • Original document
  • Permalink

Disclaimer

Fresenius SE & Co. KGaA published this content on 09 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 September 2021 09:41:06 UTC.